On behalf of European Rare Disease community,
c4c submits a shared response to the FDA consultation
about a global clinical trials network in rare diseases

On May 29th this year, the FDA opened a consultation to obtain information and comments from patients, patient advocates, the scientific community, health professionals, other regulatory and health authorities in the global community, regulated industry, and the general public regarding practical steps and successful approaches to establish a global rare disease clinical trials network.   c4c convened representatives of the…

Baby with tablets

New edition of Paediatric GCP course launching soon!

c4c is about to launch the second periodic edition of the PAEDIATRIC GCP BASIC ONLINE TRAINING COURSE. It will be available to the c4c network’s clinical site staff and healthcare professionals involved in the c4c funded clinical trials. Access to this second edition will be prioritised for the participants to the not-for-profit c4c PoV CTs…